AGT-181-102: A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human alpha-L-iduronidase (HIRMAb-IDUA) Fusion Protein, AGT-181 in Adult Patients with Mucopolysaccharidosis I (MPS I)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/24/15 → 12/31/16

Funding

  • ArmaGen, Inc. (NA)